Johnson & Johnson’s talc liability holding unit said its recently filed bankruptcy case belongs in Texas as a matter of ...
JNJ files for voluntary bankruptcy for the third time. Pfizer withdraws sickle-cell drug drug Oxbryta from worldwide markets.
A batch of votes that enabled Johnson & Johnson to advance its bankruptcy plan for talc lawsuits is disputed by plaintiffs’ ...
Leerink Partners analyst David Risinger has maintained their bullish stance on JNJ stock, giving a Buy rating on September 20. David ...
A Johnson & Johnson subsidiary got off to a contentious start Monday in its third attempt at a multibillion-dollar bankruptcy ...
Johnson & Johnson’s third effort to end lawsuits claiming its baby powder caused thousands of women to get cancer should be ...
Pointing out that "most ovarian claimants have not recovered and will not recover anything at trial," the company says the ...
A Johnson & Johnson subsidiary filed for bankruptcy protection for the third time in an effort to resolve the tens of ...
Johnson & JohnsonJNJ, via its subsidiary called Red River Talc, for the third time, filed for voluntary bankruptcy to resolve thousands of lawsuits related to its talc products. R ...
A Johnson & Johnson subsidiary filed for bankruptcy in its third attempt to settle a vast majority of cases alleging its talc ...
A Johnson & Johnson subsidiary filed bankruptcy for the third time in an ongoing effort to settle tens of thousands of ...
Despite being thrown off its rhythm twice already, Johnson & Johnson is making another go of its “Texas two-step” strategy to ...
